Compared with normal tissues, SLC2A4 were significantly reduced in luminal, HER2 positive and triple negative breast cancers (p = 1.19E-11;p = 2.43E-11;p = 6.70E-12, respectively). Here, ERBB2 is linked to triple-negative breast carcinoma.